NASHVILLE, Tenn. (July 8, 2016) — Mark Harris, Ph.D., today announced Rob Metcalf has succeeded him as chief executive officer of Concert Genetics (*formerly NextGxDx). Harris, who founded the healthcare information technology company in 2010, has elected to take a new leadership position, chief innovation officer, where his primary focus will be developing the next wave of transformative solutions for the genetic testing market.
“I couldn’t be happier to welcome Rob to the team,” Harris said. “As we move from startup to growth phase, Rob brings the skills, experience and successful track record necessary to scale Concert Genetics into a world-class company. I look forward to focusing more on product innovation and company vision – my areas of passion and expertise.”
“Mark has the elusive combination of technical expertise and business acumen necessary to start with a concept and build a thriving technology company,” Metcalf said. “He’s done an incredible job developing the company’s dynamic suite of offerings while growing the company’s customer base. I am honored to work alongside him and his talented team to accelerate the company’s growth and continue to deliver market leading genetic testing solutions for healthcare organizations.”
Metcalf brings more than a decade of experience leading technology and information services businesses. Most recently, he served as president and chief operating officer for Digital Reasoning, a Nashville-based leader in cognitive computing. Metcalf’s prior roles include multiple positions with LexisNexis, including vice president of global operations for the company’s practice management division. Metcalf received his Master of Business Administration from Harvard Business School and earned his undergraduate degree from Princeton University.
“Rob came to us highly recommended by his previous customers, colleagues and investors. We were impressed not only with his outstanding work at Digital Reasoning – where he built strong relationships with strategic customers in healthcare, financial services and national security, transforming a disruptive technology into a leading cognitive computing company – but also with how his leadership style fits with our culture,” Harris said. “With Rob on our team, we’ve never been better positioned for success.”
“As genetic testing expands exponentially, Concert Genetics is well positioned to deliver insight and intelligence to all players in the market. It’s an exciting time for the company, and I look forward to accelerating the great work already underway,” Metcalf said.
*NextGxDx became Concert Genetics in March 2017.